Brain & CNS Cancer Prevelance Report - Forecasts in 19 Major Markets 2016-2026 - Research and Markets

DUBLIN, July 4, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026" report to their offering.

Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to be over 120 types of brain tumour including glioblastoma multiforme (GBM), meningiomas and astrocytomas.

This report provides the current incident population for Brain & CNS Cancer across 19 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Russia, India, Canada, Australia, Japan, China, South Korea, Argentina, Brazil, Mexico, South Africa and Saudi Arabia) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Brain & CNS Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Brain & CNS Cancer include:

- Genetic susceptibility

- Family history of brain & CNS cancers

- Ionizing radiation exposure

- Non-ionizing radiation exposure (e.g. mobile phones, electromagnetic fields)

- Growth hormone deficiencies

- Epilepsy & seizures

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Brain & CNS Cancer Incidence

10. Location and Histopathology of Brain & CNS Cancer

- Location of Brain & CNS Cancer

- Histopathology of Neuroepithelial Brain & CNS Cancer

- Glioblastoma Multiforme and Other Types of Glial Brain & CNS Cancer

11. Abbreviations and Acronyms used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information visit http://www.researchandmarkets.com/research/5dz8gc/brain_and_cns

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]